Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):277–300.
   Web of Science ®Google Scholar
• Piver MS, Baker TR, Piedmonte M, et al. Epidemiology and etiology of ovarian cancer. Semin Oncol. 1991;18(3):177–185.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Birzele F, Kollmorgen G, et al. Targets involved in dissemination of ovarian cancer. Cancer Genomics Proteomics. 2016;13(6):407–423.
   PubMed Web of Science ®Google Scholar
• Cortez AJ, Tudrej P, Kujawa KA, et al. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018;81(1):17–38.
   PubMed Web of Science ®Google Scholar
• Wang ZH, Xu CJ. Research progress of MicroRNA in early detection of ovarian cancer. Chin Med J (Engl). 2015;128(24):3363–3370.
   PubMed Web of Science ®Google Scholar
• Toska E, Roberts SG. Mechanisms of transcriptional regulation by WT1 (Wilms’ tumour 1). Biochem J. 2014;461(1):15–32.
   PubMedGoogle Scholar
• Hohenstein P, Hastie ND. The many facets of the Wilms’ tumour gene, WT1. Hum Mol Genet. 2006;15 Spec(2):R196–201.
   Google Scholar
• Lindstedt I, Lindgren MA, Andersson E, et al. WT1 gene–its role in tumourigenesis and prospects for immunotherapeutic advances. In Vivo. 2014;28(5):675–681.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Tsuda H, Kita T, et al. Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch. 2007;451(1):27–35.
   PubMed Web of Science ®Google Scholar
• Taube ET, Denkert C, Sehouli J, et al. Wilms tumor protein 1 (WT1)– not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma. Gynecol Oncol. 2016;140(3):494–502.
   PubMed Web of Science ®Google Scholar
• Hylander B, Repasky E, Shrikant P, et al. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol. 2006;101(1):12–17.
   PubMed Web of Science ®Google Scholar
• Barbolina MV, Adley BP, Shea LD, et al. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer. 2008;112(7):1632–1641.
   PubMed Web of Science ®Google Scholar
• Gupta R, Yang Q, Dogra SK, et al. Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression. Oncogene. 2017;36(28):4014–4024.
   PubMed Web of Science ®Google Scholar
• Jomgeow T, Oji Y, Tsuji N, et al. Wilms’ tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci. 2006;97(4):259–270.
   PubMed Web of Science ®Google Scholar
• Lee BH, Hecht JL, Pinkus JL, et al. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am J Clin Pathol. 2002;117(5):745–750.
   PubMed Web of Science ®Google Scholar
• Vergara D, Merlot B, Lucot JP, et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 2010;291(1):59–66.
   PubMed Web of Science ®Google Scholar
• Lee GA, Hwang KA, Choi KC. Roles of dietary phytoestrogens on the regulation of epithelial-mesenchymal transition in diverse cancer metastasis. Toxins (Basel). 2016;8(6):162.
   PubMed Web of Science ®Google Scholar
• Gloushankova NA, Zhitnyak IY, Rubtsova SN. Role of epithelial-mesenchymal transition in tumor progression. Biochemistry (Mosc). 2018;83(12):1469–1476.
   PubMed Web of Science ®Google Scholar
• Martínez-Estrada OM, Lettice LA, Essafi A, et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nature Genet. 2010;42(1):89–93.
   PubMed Web of Science ®Google Scholar
• Brett A, Pandey S, Fraizer G. The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells. Mol Cancer. 2013;12:3.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhu W, Qian J, et al. WT1 promotes invasion of NSCLC via suppression of CDH1. J Thorac Oncol. 2013;8(9):1163–1169.
   PubMed Web of Science ®Google Scholar
• Høgdall EV, Christensen L, Kjaer SK, et al. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish “MALOVA” ovarian cancer study. Gynecol Oncol. 2007;106(2):318–324.
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6.
   PubMed Web of Science ®Google Scholar
• Győrffy B, Surowiak P, Budczies J, et al. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2014;9(10):e111842.
   Web of Science ®Google Scholar
• Xu S, Mou H, Lü G, et al. Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip. Chin Med J (Engl). 2002;115(1):36–41.
   PubMed Web of Science ®Google Scholar
• Sun P, Jiang Z, Chen X, et al. Decreasing the ratio of matriptase/HAI-1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer. Mol Med Rep. 2016;14(2):1465–1474.
   PubMed Web of Science ®Google Scholar
• Ye F, Chen C, Qin J, et al. Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. Faseb J. 2015;29(10):4268–4272.
   PubMed Web of Science ®Google Scholar
• Lau MT, So WK, Leung PC. Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells. PLoS One. 2013;8(3):e59083.
   PubMed Web of Science ®Google Scholar
• Kim EY, Kim A, Kim SK, et al. Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells. Respir Res. 2014;15(1):26.
   PubMedGoogle Scholar
• Yang L, Han Y, Suarez Saiz F, et al. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007;21(5):868–876.
   PubMed Web of Science ®Google Scholar
• Qi XW, Zhang F, Yang XH, et al. High Wilms tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer. Oncol Rep. 2012;28(4):1231–1236.
   PubMed Web of Science ®Google Scholar
• Oji Y, Inohara H, Nakazawa M, et al. Overexpression of the Wilms’ tumor gene WT1 in head and neck squamous cell carcinoma. Cancer Sci. 2003;94(6):523–529.
   PubMed Web of Science ®Google Scholar
• Al-Hussaini M, Stockman A, Foster H, et al. 1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology. 2004;44(2):109–115.
   PubMed Web of Science ®Google Scholar
• Netinatsunthorn W, Hanprasertpong J, Dechsukhum C, et al. WT1 gene expression as a prognostic marker in advanced serous carcinoma: an immunohistochemical study. BMC Cancer. 2006;6:90.
   PubMed Web of Science ®Google Scholar
• Mitra AK, Davis DA, Tomar S, et al. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Gynecol Oncol. 2015;138(2):372–377.
   PubMed Web of Science ®Google Scholar
• Smith BN, Bhowmick NA. Role of EMT in Metastasis and Therapy Resistance. J Clin Med. 2016;5(2):17.
   PubMed Web of Science ®Google Scholar
• Chau YY, Hastie ND. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends Genet. 2012;28(10):515–524.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429–1437.
   PubMed Web of Science ®Google Scholar
• Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7(6):1267–1278.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang X, Salmon M, et al. TGF beta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim Biophys Acta. 2007;1773(3):427–439.
   PubMed Web of Science ®Google Scholar
• Gilles C, Polette M, Mestdagt M, et al. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003;63(10):2658–2664.
   PubMed Web of Science ®Google Scholar
• Mo H, He J, Yuan Z, et al. WT1 is involved in the Akt-JNK pathway dependent autophagy through directly regulating Gas1 expression in human osteosarcoma cells. Biochem Biophys Res Commun. 2016;478(1):74–80.
   PubMed Web of Science ®Google Scholar
• Parenti R, Cardile V, Graziano AC, et al. Wilms’ tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line. PLoS One. 2014;9(12):e114333.
   PubMed Web of Science ®Google Scholar
• Hu Q, Gao F, Tian W, et al. 1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest. 2011;121(1):174–183.
   PubMed Web of Science ®Google Scholar
• Vicent S, Chen R, Sayles LC, et al. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest. 2010;120(11):3940–3952.
   PubMed Web of Science ®Google Scholar
• Morrison DJ, Kim MK, Berkofsky-Fessler W, et al. WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression. Mol Cancer Res. 2008;6(7):1225–1231.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang J, Li X, et al. Role of the Wilms’ tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms. Oncol Rep. 2014;32(6):2680–2686.
   PubMed Web of Science ®Google Scholar
• Gross I, Morrison DJ, Hyink DP, et al. The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development. J Biol Chem. 2003;278(42):41420–41430.
   PubMed Web of Science ®Google Scholar
• Hanafusa H, Torii S, Yasunaga T, et al. Sprouty 1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol. 2002;4(11):850–858.
   PubMed Web of Science ®Google Scholar